Behandlingsniveau og behandlingsstop ved benign lungesygdom

Translated title of the contribution: Treatment limitations or discontinuation in patients with benign pulmonary diseases

Anita Rath Sørensen, Elisabeth Bendstrup, Anders Løkke, Ingrid Louise Titlestad, Jens Ulrik Stæhr Jensen, Laura Hohwu Thomsen, Nassim Bazeghi Roberts, Pia Holland Gjørup, Saher Burhan Shaker, Svend Gundestrup, Jon Torgny Rostrup Wilcke, Ulla Moller Weinreich, Kristoffer Marsaa

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients‘ and informal caregivers‘ wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient’s wishes, the disease stage and progression and potential reversible components.
Translated title of the contributionTreatment limitations or discontinuation in patients with benign pulmonary diseases
Original languageDanish
Article numberV04180270
JournalUgeskrift for Laeger
Volume181
Issue number13
ISSN0041-5782
Publication statusPublished - 2019

Fingerprint

Dive into the research topics of 'Treatment limitations or discontinuation in patients with benign pulmonary diseases'. Together they form a unique fingerprint.

Cite this